Dubai: HealthPlus Fertility, a Mubadala Health partner, has successfully concluded the HealthPlus Middle East Fertility Conference. The fifth edition of the annual industry event, held under the theme ‘Preserving Hope and Empowering Fertility Choices,’ attracted over 1,000 participants from 23 countries.
The event was attended by leading experts, researchers, and practitioners in the field of fertility. The sessions explored the latest advances in reproductive health technologies and challenges regarding infertility treatment. The event featured three days of lively discussions, interactions, debates, and workshops for the world’s leading fertility experts at The Address, Dubai Marina.
This year’s conference shed light on the transformative advancements in fertility treatments. It was insightful to hear about positive patient journeys and how the latest technology can help couples achieve their dreams. Our collective aim is to build on this foundation, ensuring that future gatherings are even more influential and impactful in shaping the course of fertility solutions.
Dr. Walid Sayed, Consultant, Reproductive Endocrinology & Infertility, HealthPlus Fertility Centre, shared.
Mr. Ahmed Elbohoty, Professor of Obstetrics and Gynecology, Consultant Obstetrics, Gynecology, and Reproductive Medicine/Fertility (IVF), HealthPlus Fertility Centre, and Conference Chair, commented that “the discussions held during this year’s HealthPlus Middle East Conference were some of the most thought-provoking and inspiring. The often-emotive topic of fertility was discussed by leading experts in the field, who gave their own fascinating insights into this ever-developing practice.”
“Our delegates have not only gained knowledge but also forged invaluable connections with their peers. We hope that these insights will empower their daily practices and drive a new era of fertility solutions,” Mr. Elbohoty added.
The major topics highlighted during the sessions included ethical and legal issues involving IVF, Fertility Preservation, Social Egg Freezing: For Unmarried Women between 30 to 35 years, Artificial Intelligence (AI) in Assisted Reproductive Technology (ART) and Ovarian Tissue Cryopreservation -Transplantation.
Conference debates further featured experts from across multiple countries who shared personal stories of success and evidence-based treatment options for patients at a crossroads.